Bioaffinity Technologies Inc (BIAF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Sales | 1,511 | 1,352 | 1,593 | 1,446 | 1,270 |
| Cost of Goods | 1,088 | 929 | 900 | 942 | 1,017 |
| Gross Profit | 423 | 423 | 693 | 504 | 253 |
| Operating Expenses | 3,845 | 4,969 | 4,730 | 3,739 | 2,785 |
| Operating Income | -3,335 | -3,617 | -3,137 | -2,293 | -2,516 |
| Interest Expense | 12 | 15 | 13 | 5 | 11 |
| Other Income | -20 | 1 | 16 | -2,750 | -1,506 |
| Pre-tax Income | -3,366 | -3,631 | -3,134 | -5,048 | -4,032 |
| Income Tax | N/A | N/A | 3 | 3 | 29 |
| Net Income Continuous | -3,366 | -3,631 | -3,138 | -5,051 | -4,061 |
| Net Income | $-3,366 | $-3,631 | $-3,138 | $-5,051 | $-4,061 |
| EPS Basic Total Ops | -0.64 | -0.81 | 5.95 | -4.74 | -5.07 |
| EPS Basic Continuous Ops | -0.64 | -0.81 | 6.06 | -4.74 | -5.07 |
| EPS Diluted Total Ops | -0.64 | -0.81 | 5.95 | -4.74 | -5.07 |
| EPS Diluted Continuous Ops | -0.64 | -0.81 | 6.06 | -4.74 | -5.07 |
| EPS Diluted Before Non-Recurring Items | -0.64 | -0.81 | -1.11 | -2.70 | -3.90 |
| EBITDA(a) | $-3,273 | $-3,503 | $-3,013 | $-2,180 | $-2,402 |